LFCR
Price
$4.40
Change
+$0.05 (+1.15%)
Updated
Sep 4 closing price
Capitalization
166.55M
62 days until earnings call
Intraday BUY SELL Signals
PAHC
Price
$38.25
Change
-$0.33 (-0.86%)
Updated
Sep 4 closing price
Capitalization
1.55B
67 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LFCR vs PAHC

LFCR vs PAHC Comparison Chart in %
loading
loading
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teva Pharmaceutical Industries Limited (NYSE:TEVA), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), BioCryst Pharmaceuticals (NASDAQ:BCRX), Bausch Health Companies (NYSE:BHC), Tilray Brands Inc. (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 4.08B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was -1%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 37%. GELS experienced the highest price growth at 62%, while BTAI experienced the biggest fall at -59%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was -37% and the average quarterly volume growth was 70%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 64
Price Growth Rating: 55
SMR Rating: 88
Profit Risk Rating: 82
Seasonality Score: -16 (-100 ... +100)

Market Cap

The average market capitalization across the group is 859.99M. The market cap for tickers in the group ranges from 166.55M to 1.55B. PAHC holds the highest valuation in this group at 1.55B. The lowest valued company is LFCR at 166.55M.

High and low price notable news

The average weekly price growth across all stocks in the group was -1%. For the same group, the average monthly price growth was 3%, and the average quarterly price growth was -28%. PAHC experienced the highest price growth at 2%, while LFCR experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the group was 40%. For the same stocks of the group, the average monthly volume growth was 53% and the average quarterly volume growth was -13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 49
Price Growth Rating: 64
SMR Rating: 67
Profit Risk Rating: 83
Seasonality Score: -50 (-100 ... +100)
VS
LFCR vs. PAHC commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and PAHC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2026
Stock price -- (LFCR: $4.40 vs. PAHC: $38.25)
Brand notoriety: LFCR and PAHC are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 194% vs. PAHC: 61%
Market capitalization -- LFCR: $166.55M vs. PAHC: $1.55B
LFCR [@Pharmaceuticals: Generic] is valued at $166.55M. PAHC’s [@Pharmaceuticals: Generic] market capitalization is $1.55B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 2 TA indicator(s) are bullish while PAHC’s TA Score has 4 bullish TA indicator(s).

  • LFCR’s TA Score: 2 bullish, 6 bearish.
  • PAHC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PAHC is a better buy in the short-term than LFCR.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а -3.08% price change this week, while PAHC (@Pharmaceuticals: Generic) price change was +1.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.17%. For the same industry, the average monthly price growth was +0.32%, and the average quarterly price growth was +36.80%.

Reported Earning Dates

LFCR is expected to report earnings on Nov 06, 2026.

PAHC is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.17% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PAHC($1.55B) has a higher market cap than LFCR($167M). LFCR has higher P/E ratio than PAHC: LFCR (51.23) vs PAHC (15.74). PAHC YTD gains are higher at: 3.375 vs. LFCR (-46.210). PAHC has higher annual earnings (EBITDA): 233M vs. LFCR (-8.81M). LFCR has less debt than PAHC: LFCR (149M) vs PAHC (789M). PAHC has higher revenues than LFCR: PAHC (1.52B) vs LFCR (129M).
LFCRPAHCLFCR / PAHC
Capitalization167M1.55B11%
EBITDA-8.81M233M-4%
Gain YTD-46.2103.375-1,369%
P/E Ratio51.2315.74325%
Revenue129M1.52B8%
Total Cash20.8MN/A-
Total Debt149M789M19%
FUNDAMENTALS RATINGS
LFCR vs PAHC: Fundamental Ratings
LFCR
PAHC
OUTLOOK RATING
1..100
3441
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
10066
SMR RATING
1..100
10034
PRICE GROWTH RATING
1..100
7850
P/E GROWTH RATING
1..100
594
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (12) in the Pharmaceuticals Major industry is significantly better than the same rating for LFCR (89) in the Industrial Specialties industry. This means that PAHC’s stock grew significantly faster than LFCR’s over the last 12 months.

PAHC's Profit vs Risk Rating (66) in the Pharmaceuticals Major industry is somewhat better than the same rating for LFCR (100) in the Industrial Specialties industry. This means that PAHC’s stock grew somewhat faster than LFCR’s over the last 12 months.

PAHC's SMR Rating (34) in the Pharmaceuticals Major industry is significantly better than the same rating for LFCR (100) in the Industrial Specialties industry. This means that PAHC’s stock grew significantly faster than LFCR’s over the last 12 months.

PAHC's Price Growth Rating (50) in the Pharmaceuticals Major industry is in the same range as LFCR (78) in the Industrial Specialties industry. This means that PAHC’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's P/E Growth Rating (5) in the Industrial Specialties industry is significantly better than the same rating for PAHC (94) in the Pharmaceuticals Major industry. This means that LFCR’s stock grew significantly faster than PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRPAHC
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 1 day ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signal:
Gain/Loss:
PAHC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPLB21.310.02
+0.09%
State Street SPDR Port L/T Corp Bd ETF
SDSI51.010.03
+0.06%
American Century® Short Dur Str Inc ETF
IBIH25.58-0.02
-0.08%
iShares iBonds Oct 2031 Term Tips ETF
MAVF139.62-0.36
-0.26%
MATRIX ADVISORS VALUE ETF
ELIL27.49-0.63
-2.26%
Direxion Daily LLY Bull 2X Shares

LFCR and Stocks

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
+1.15%
SHPH - LFCR
31%
Poorly correlated
+0.57%
COLL - LFCR
28%
Poorly correlated
-0.72%
PAHC - LFCR
27%
Poorly correlated
-0.86%
TLRY - LFCR
27%
Poorly correlated
-0.66%
VTRS - LFCR
25%
Poorly correlated
-0.35%
More

PAHC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with ZTS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-0.86%
ZTS - PAHC
57%
Loosely correlated
-0.63%
ELAN - PAHC
47%
Loosely correlated
+0.33%
VTRS - PAHC
29%
Poorly correlated
-0.35%
LFCR - PAHC
27%
Poorly correlated
+1.15%
AKBA - PAHC
27%
Poorly correlated
-0.87%
More